KemPharm Inc. (NASDAQ: KMPH) stock jumped 12.66% on Thursday to $6.85 against a previous-day closing price of $6.08. With 0.41 million shares changing hands, the volume of the stock remained heavier than its average volume of 0.3 million shares. During the session, the Biotechnology company that operates in the wider Healthcare sector, reached to the highest price of $6.92 whereas the lowest price dropped to $6.29. The 52-week range on KMPH shows that it touched its highest point at $10.80 and its lowest point at $4.00 during that stretch. It currently has a 1-year price target of $19.50. Beta for the stock currently stands at 2.77.
Do You Know The Best Place To Find Gains In Volatile Markets?
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free.
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of KMPH was up-trending over the past week, with a rise of 15.51%, but this was up by 24.09% over a month. Three-month performance surged to 62.32% while six-month performance rose 29.49%. The stock lost -22.34% in the past year, while it has lost -21.35% so far this year.
BlueFire Equipment Corporation (BLFR) stock jumped 11.54% on Thursday to $0.0725 against a previous-day closing price of $0.0650. During the session, the company reached to the highest price of $0.0990 whereas the lowest price it dropped to was $0.0501. The 52-week range on BLFR shows that it touched its highest point at $0.1200 and its lowest point at $0.0048 during that stretch. Beta for the stock currently stands at 1.42.
BlueFire Equipment, Corp., a company which conducts acquisitions of high promise businesses in the agricultural sector, secured an acquisition of Miracle Life Farm LLC, a family-run Floridian farm.
Miracle Life Farm LLC is a farming business which specializes in exotic fruit production which includes premium fruits such as Mamay, the Sugar Apple, as well as Thai Guava. The farm is spread across 13 acres of cultivational land, with its produce sold on the wholescale model across the United States under the USDA. Through this approach, Miracle Life Farm LLC is sold to consumers in some of the top American supermarket chains such as Windixie and Presidente.
After six years of delivering quality fruits to the American consumer, Miracle Life has set its sights high and is ready to broaden its market presence. The acquisition deal involves a purchase of an 81% controlling stake in the business by BLFR, whereas the remainder is retained by the founders of Miracle Life. Going public brings a wide range of benefits to the business, including access to the financing of capital markets, as well as the opportunity for lucrative acquisitions for the purposes of synergy-creation, and ultimately shareholder value maximization.
As of June 20, 2022. Miracle Life had assets of $3,133,827.95 and revenue of $307,423.21. The company says plans for expansion and restructuring are in progress and will be revealed in the near future.
Champions Oncology Inc. (NASDAQ: CSBR) stock jumped 12.47% on Friday to $8.75 against a previous-day closing price of $7.78. With 31946.0 shares changing hands, the volume of the stock remained heavier than its average volume of 7950.0 shares. During the session, the Biotechnology company that operates in the wider Healthcare sector reached to the highest price of $8.97 whereas the lowest price dropped to $7.66. The 52-week range on CSBR shows that it touched its highest point at $10.74 and its lowest point at $6.81 during that stretch. It currently has a 1-year price target of $15.67. Beta for the stock currently stands at 0.92.
Float and Shares Shorts
At present, 13.28 million CSBR shares are outstanding with a float of 10.21 million shares on hand for trading. On Aug 30, 2022, short shares totaled 63360.0, which was 0.47% higher than short shares on Jul 28, 2022. In addition to Dr. Ronnie Morris M.D. as the firm’s Pres, CEO & Director, Mr. David Barry Miller M.B.A. serves as its Chief Financial Officer.